These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 21344922

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Discoveries, target identifications, and biological applications of natural products that inhibit splicing factor 3B subunit 1.
    Pham D, Koide K.
    Nat Prod Rep; 2016 May 04; 33(5):637-47. PubMed ID: 26812544
    [Abstract] [Full Text] [Related]

  • 23. FR901464: total synthesis, proof of structure, and evaluation of synthetic analogues.
    Thompson CF, Jamison TF, Jacobsen EN.
    J Am Chem Soc; 2001 Oct 17; 123(41):9974-83. PubMed ID: 11592876
    [Abstract] [Full Text] [Related]

  • 24. Cytotoxic Spliceostatin Analogs from Pseudomonas sp.
    Zhao H, Zhang B, Ma LF, Shi LM, Zhan ZJ.
    Chem Biodivers; 2019 Sep 17; 16(9):e1900266. PubMed ID: 31298476
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Anticancer agents from the Australian tropical rainforest: Spiroacetals EBC-23, 24, 25, 72, 73, 75 and 76.
    Dong L, Schill H, Grange RL, Porzelle A, Johns JP, Parsons PG, Gordon VA, Reddell PW, Williams CM.
    Chemistry; 2009 Oct 26; 15(42):11307-18. PubMed ID: 19750529
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Optimization of antitumor modulators of pre-mRNA splicing.
    Lagisetti C, Palacios G, Goronga T, Freeman B, Caufield W, Webb TR.
    J Med Chem; 2013 Dec 27; 56(24):10033-44. PubMed ID: 24325474
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Global analysis of pre-mRNA subcellular localization following splicing inhibition by spliceostatin A.
    Yoshimoto R, Kaida D, Furuno M, Burroughs AM, Noma S, Suzuki H, Kawamura Y, Hayashizaki Y, Mayeda A, Yoshida M.
    RNA; 2017 Jan 27; 23(1):47-57. PubMed ID: 27754875
    [Abstract] [Full Text] [Related]

  • 36. Microbial and Natural Metabolites That Inhibit Splicing: A Powerful Alternative for Cancer Treatment.
    Martínez-Montiel N, Rosas-Murrieta NH, Martínez-Montiel M, Gaspariano-Cholula MP, Martínez-Contreras RD.
    Biomed Res Int; 2016 Jan 27; 2016():3681094. PubMed ID: 27610372
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Splicing factor SF3b as a target of the antitumor natural product pladienolide.
    Kotake Y, Sagane K, Owa T, Mimori-Kiyosue Y, Shimizu H, Uesugi M, Ishihama Y, Iwata M, Mizui Y.
    Nat Chem Biol; 2007 Sep 27; 3(9):570-5. PubMed ID: 17643112
    [Abstract] [Full Text] [Related]

  • 40. New antitumor substances, FR901463, FR901464 and FR901465. II. Activities against experimental tumors in mice and mechanism of action.
    Nakajima H, Hori Y, Terano H, Okuhara M, Manda T, Matsumoto S, Shimomura K.
    J Antibiot (Tokyo); 1996 Dec 27; 49(12):1204-11. PubMed ID: 9031665
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.